OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit


Fatih M. Uckun

Fatih M. Uckun

Professor in the Department of Pediatrics
Keck School of Medicine
University of Southern California


Fatih M. Uckun, M.D., Ph.D, is a member of the American Society for Clinical Investigation (ASCI), an honor society for physician-scientists, and an active member of several professional organizations, including ASH, ASCO, and AACR. He earned his doctoral degrees at University of Heidelberg and completed his residency training in Pediatrics, fellowship training in Hematology/Oncology/Blood and Bone Marrow Stem Cell Transplantation, as well as postdoctoral research training in Immunology at the University of Minnesota. Currently, he is a Professor in the Department of Pediatrics, Keck School of Medicine, University of Southern California. He is the Head of Translational Research in Leukemia and Lymphoma at the Children's Center for Cancer and Blood Diseases/Children's Hospital Los Angeles. He directs an NIH/NCI-funded Nanomedicine R&D Program at the Children’s Hospital Los Angeles. Dr. Uckun serves as the Chair of the Biotargeting Working Group as well as a member of the Coordinating and Governance Committee (CGC) of the NCI Alliance for Nanotechnology in Cancer. Dr. Uckun has more than 20 years of professional experience in developmental therapeutics and biopharmaceuticals. He has published more than 450 peer-reviewed papers and he has authored numerous review articles and book chapters. He received numerous awards including the Stohlman Memorial Award of the Leukemia Society of America. He is the Editor-in-Chief of Journal of Nanomedicine and Nanotechnology and has served as a member of several editorial boards and NIH grant review/special emphasis panels.


Translational Research aimed at identifying new molecular targets in treatment of cancer and inflammatory disorders; Targeted Nanoparticles; Radiation Biology, Systems Immunobiology, Biopharmaceuticals; Molecular Epidemiology of Cancer; Chemoprevention of Cancer; Epigenetic regulation of cancer growth; Innate Immunity;